ID   ZN337_HUMAN             Reviewed;         751 AA.
AC   Q9Y3M9; B4DSM2; Q9Y3Y5;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 2.
DT   28-JUN-2023, entry version 197.
DE   RecName: Full=Zinc finger protein 337;
GN   Name=ZNF337;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 256-751 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-458, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-458, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       Q9Y3M9; Q13137: CALCOCO2; NbExp=3; IntAct=EBI-714987, EBI-739580;
CC       Q9Y3M9; Q86Z20: CCDC125; NbExp=3; IntAct=EBI-714987, EBI-11977221;
CC       Q9Y3M9; Q14749: GNMT; NbExp=3; IntAct=EBI-714987, EBI-744239;
CC       Q9Y3M9; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-714987, EBI-2549423;
CC       Q9Y3M9; Q6A162: KRT40; NbExp=3; IntAct=EBI-714987, EBI-10171697;
CC       Q9Y3M9; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-714987, EBI-10172290;
CC       Q9Y3M9; Q5JR59: MTUS2; NbExp=3; IntAct=EBI-714987, EBI-742948;
CC       Q9Y3M9; Q96KN7: RPGRIP1; NbExp=3; IntAct=EBI-714987, EBI-1050213;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y3M9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y3M9-2; Sequence=VSP_055949;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299811; BAG61684.1; -; mRNA.
DR   EMBL; AL031673; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021298; AAH21298.1; -; mRNA.
DR   EMBL; AL049942; CAB43216.1; -; mRNA.
DR   CCDS; CCDS13174.1; -. [Q9Y3M9-1]
DR   PIR; T08674; T08674.
DR   RefSeq; NP_001277190.1; NM_001290261.1. [Q9Y3M9-1]
DR   RefSeq; NP_056470.1; NM_015655.3. [Q9Y3M9-1]
DR   RefSeq; XP_005260759.1; XM_005260702.3. [Q9Y3M9-2]
DR   RefSeq; XP_006723621.1; XM_006723558.3. [Q9Y3M9-1]
DR   RefSeq; XP_011527521.1; XM_011529219.2. [Q9Y3M9-1]
DR   RefSeq; XP_016883291.1; XM_017027802.1.
DR   RefSeq; XP_016883292.1; XM_017027803.1. [Q9Y3M9-2]
DR   AlphaFoldDB; Q9Y3M9; -.
DR   SMR; Q9Y3M9; -.
DR   BioGRID; 117583; 15.
DR   IntAct; Q9Y3M9; 12.
DR   MINT; Q9Y3M9; -.
DR   STRING; 9606.ENSP00000365619; -.
DR   iPTMnet; Q9Y3M9; -.
DR   PhosphoSitePlus; Q9Y3M9; -.
DR   BioMuta; ZNF337; -.
DR   DMDM; 20141069; -.
DR   EPD; Q9Y3M9; -.
DR   jPOST; Q9Y3M9; -.
DR   MassIVE; Q9Y3M9; -.
DR   MaxQB; Q9Y3M9; -.
DR   PaxDb; Q9Y3M9; -.
DR   PeptideAtlas; Q9Y3M9; -.
DR   ProteomicsDB; 5036; -.
DR   ProteomicsDB; 86050; -. [Q9Y3M9-1]
DR   Antibodypedia; 10099; 152 antibodies from 23 providers.
DR   DNASU; 26152; -.
DR   Ensembl; ENST00000252979.6; ENSP00000252979.5; ENSG00000130684.14. [Q9Y3M9-1]
DR   Ensembl; ENST00000376436.5; ENSP00000365619.1; ENSG00000130684.14. [Q9Y3M9-1]
DR   GeneID; 26152; -.
DR   KEGG; hsa:26152; -.
DR   MANE-Select; ENST00000252979.6; ENSP00000252979.5; NM_015655.4; NP_056470.1.
DR   UCSC; uc002wva.4; human. [Q9Y3M9-1]
DR   AGR; HGNC:15809; -.
DR   CTD; 26152; -.
DR   DisGeNET; 26152; -.
DR   GeneCards; ZNF337; -.
DR   HGNC; HGNC:15809; ZNF337.
DR   HPA; ENSG00000130684; Low tissue specificity.
DR   neXtProt; NX_Q9Y3M9; -.
DR   OpenTargets; ENSG00000130684; -.
DR   PharmGKB; PA38043; -.
DR   VEuPathDB; HostDB:ENSG00000130684; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000164820; -.
DR   HOGENOM; CLU_002678_44_5_1; -.
DR   InParanoid; Q9Y3M9; -.
DR   OMA; KTVMGPQ; -.
DR   OrthoDB; 4668649at2759; -.
DR   PhylomeDB; Q9Y3M9; -.
DR   TreeFam; TF343410; -.
DR   PathwayCommons; Q9Y3M9; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   SignaLink; Q9Y3M9; -.
DR   BioGRID-ORCS; 26152; 7 hits in 1177 CRISPR screens.
DR   ChiTaRS; ZNF337; human.
DR   GenomeRNAi; 26152; -.
DR   Pharos; Q9Y3M9; Tdark.
DR   PRO; PR:Q9Y3M9; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9Y3M9; protein.
DR   Bgee; ENSG00000130684; Expressed in cerebellar hemisphere and 203 other tissues.
DR   Genevisible; Q9Y3M9; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 19.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24393:SF130; ENDOTHELIAL ZINC FINGER PROTEIN INDUCED BY TUMOR NECROSIS FACTOR ALPHA; 1.
DR   PANTHER; PTHR24393; ZINC FINGER PROTEIN; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 15.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 20.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 12.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 19.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 20.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..751
FT                   /note="Zinc finger protein 337"
FT                   /id="PRO_0000047540"
FT   DOMAIN          12..83
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         180..202
FT                   /note="C2H2-type 1; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         208..230
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         236..258
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         264..286
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         292..314
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         320..342
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         348..370
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         376..398
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         404..426
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         432..454
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         460..482
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         488..510
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         516..538
FT                   /note="C2H2-type 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         544..566
FT                   /note="C2H2-type 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         572..594
FT                   /note="C2H2-type 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         600..622
FT                   /note="C2H2-type 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         628..650
FT                   /note="C2H2-type 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         656..679
FT                   /note="C2H2-type 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         685..707
FT                   /note="C2H2-type 19"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         713..735
FT                   /note="C2H2-type 20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          101..163
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        101..116
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        147..162
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CROSSLNK        458
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         52..83
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055949"
FT   VARIANT         17
FT                   /note="V -> I (in dbSNP:rs926487)"
FT                   /id="VAR_024213"
FT   VARIANT         467
FT                   /note="R -> G (in dbSNP:rs16987972)"
FT                   /id="VAR_052814"
FT   CONFLICT        476
FT                   /note="T -> A (in Ref. 4; CAB43216)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        653
FT                   /note="E -> V (in Ref. 4; CAB43216)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   751 AA;  86875 MW;  482D9F9A57EC980E CRC64;
     MGPQGARRQA FLAFGDVTVD FTQKEWRLLS PAQRALYREV TLENYSHLVS LGILHSKPEL
     IRRLEQGEVP WGEERRRRPG PCAGIYAEHV LRPKNLGLAH QRQQQLQFSD QSFQSDTAEG
     QEKEKSTKPM AFSSPPLRHA VSSRRRNSVV EIESSQGQRE NPTEIDKVLK GIENSRWGAF
     KCAERGQDFS RKMMVIIHKK AHSRQKLFTC RECHQGFRDE SALLLHQNTH TGEKSYVCSV
     CGRGFSLKAN LLRHQRTHSG EKPFLCKVCG RGYTSKSYLT VHERTHTGEK PYECQECGRR
     FNDKSSYNKH LKAHSGEKPF VCKECGRGYT NKSYFVVHKR IHSGEKPYRC QECGRGFSNK
     SHLITHQRTH SGEKPFACRQ CKQSFSVKGS LLRHQRTHSG EKPFVCKDCE RSFSQKSTLV
     YHQRTHSGEK PFVCRECGQG FIQKSTLVKH QITHSEEKPF VCKDCGRGFI QKSTFTLHQR
     THSEEKPYGC RECGRRFRDK SSYNKHLRAH LGEKRFFCRD CGRGFTLKPN LTIHQRTHSG
     EKPFMCKQCE KSFSLKANLL RHQWTHSGER PFNCKDCGRG FILKSTLLFH QKTHSGEKPF
     ICSECGQGFI WKSNLVKHQL AHSGKQPFVC KECGRGFNWK GNLLTHQRTH SGEKPFVCNV
     CGQGFSWKRS LTRHHWRIHS KEKPFVCQEC KRGYTSKSDL TVHERIHTGE RPYECQECGR
     KFSNKSYYSK HLKRHLREKR FCTGSVGEAS S
//
